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In 2012, a mutant porcine circovirus type 2 (mPCV2) strain was identified in cases of PCV-
associated disease (PCVAD) in the USA. The mPCV2 had an additional amino acid, lysine (K), in
the capsid at position 234. The objectives of this study were to compare the pathogenicity of
mPCV2, PCV2a and PCV2b in pigs using biologically pure infectious virus stocks derived from
respective infectious DNA clones, and to investigate the importance of genotype-specific ORF2
and the presence of lysine at position 234 of the capsid. A total of 47, 2-week-old, caesarean-
derived, colostrum-deprived (CDCD) pigs were assigned to one of seven groups. At 3 weeks of
age, the pigs were experimentally inoculated with saline, PCV2a, PCV2b, mPCV2, PCV2b-234-K
(lysine addition in ORF2), chimeric PCV2b-ORF1/mPCV2-ORF2 or reciprocal chimeric mPCV2-
ORF1/PCV2b-ORF2. All pigs were necropsied 21 days post-infection (p.i.). Gross lesions were
limited to visible icterus and loss of body condition in a portion of the mPCV2 pigs. The amount of
PCV2 DNA was significantly higher in pigs inoculated with mPCV2 compared with PCV2b in sera
at 7 days p.i. and faecal swabs at 14 days p.i. Based on lymphoid lesions, a higher prevalence of
PCVAD was seen in pigs infected with PCV2s containing the additional 234-K (64.3%)
compared with those infected with a PCV2 with the regular 233 bp ORF2 (40%). Results
indicated that all PCV2 isolates were capable of inducing severe lesions and disease in the
CDCD pig model, and there was no significant difference in virulence.
INTRODUCTION
Porcine circovirus type 2 (PCV2) has been associated with
a number of diseases in growing pigs, including systemic
disease, respiratory disease, enteric disease, and porcine
dermatitis and nephropathy syndrome, collectively known
as PCV-associated disease (PCVAD) (Opriessnig et al.,
2007). PCV2 is a small, single-stranded, non-enveloped,
circular DNA virus containing a genome of 1766–1768 nt
(Cheung et al., 2007; Tischer et al., 1974). There are two
main ORFs: ORF1 encoding two proteins associated with
virus replication designated Rep and Rep9, and ORF2
encoding the capsid protein (Finsterbusch & Mankertz,
2009; Nawagitgul et al., 2000).
Several PCV2 genotypes have been recognized and
designated with consecutive lower-case letters, i.e. PCV2a,
PCV2b, PCV2c, PCV2d and PCV2e (Dupont et al., 2008;
Gagnon et al., 2007; Guo et al., 2010; Jantafong et al.,
2011). There is still an ongoing debate on the nomenclature
of PCV2 genotypes; however, it is generally accepted to use
the guidelines established by the European Union consor-
tium on PCV diseases (http://www.pcvd.net) which recom-
mends that the ORF2 sequences of PCV2 are assigned to
different genotypes when the genetic distance between
them is at least 0.035 (Grau-Roma et al., 2008). Amongst
all PCV2 genotypes, PCV2a was the predominant strain
prior to 2000 and PCV2b is currently the main genotype
in the global pig population (Segale´s et al., 2008).
Interestingly, initial introduction of PCV2b in PCV2a-
infected herds was commonly associated with severe
PCVAD outbreaks (Cheung et al., 2007; Gagnon et al.,
2007). However, evidence from experimental inoculations
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suggested that PCV2a and PCV2b were similar in virulence
(Fort et al., 2008; Opriessnig et al., 2008), although dif-
ferences in virulence have been documented within
subtypes (Opriessnig et al., 2006b).
In the USA, several epidemiological investigations of PCV2
genotypes have been conducted (Fenaux et al., 2000; Shen
et al., 2010a, 2012), and PCV2a and PCV2b were the only
genotypes identified. In 2012, a variant PCV2 strain with an
elongation of ORF2 by one amino acid, lysine (K), was
detected in several PCVAD cases (Xiao et al., 2012). This
strain, which is also known as mPCV2, has a shift from TTA
to CTT in the genomic sequence resulting in a mutation of
the stop codon (from UAA to AAG) in the ORF2,
subsequently leading to expression of the additional amino
acid residue lysine (Guo et al., 2011). An almost identical
mPCV2 had been identified previously in China (Guo et al.,
2010); however, sequences deposited in the GenBank
database indicated that the mPCV2 virus was already
present in China by 2006 (GenBank accession numbers
JX679498 and JQ653449) and mPCV2 variants can be traced
back to 2002 in China (Wang et al., 2009). When compared
with the classical Chinese PCV2a and PCV2b isolates using a
Chinese conventional pig model, enhanced virulence of
mPCV2 was suggested (Guo et al., 2012).
The objectives of this present study were to construct an
infectious clone of the USA mPCV2 in order to prepare a
biologically pure infectious stock of mPCV2, to compare
the pathogenicity of mPCV2, PCV2a and PCV2b side-by-
side in a caesarean-derived, colostrum-deprived (CDCD)
pig model, and to further investigate the importance of
PCV2-genotype-specific ORF2 and the addition of the
amino acid lysine at position 234 by utilizing chimeric and
reciprocal chimeric PCV2b/mPCV2 viruses.
RESULTS
Confirmation of the correct virus genotype in each
group
Differential PCR on serum samples collected at 21 days
post-infection (p.i.) indicated the presence of the correct
ORF2 sequences in each of the groups except for the
chimeric PCV2 group where the ORF2 of both PCV2b and
mPCV2 was detected. Further sequencing analysis con-
firmed the results suggestive of a contamination. Therefore,
the results for this particular group were excluded and not
analysed. However, excluding this group from the analysis
had no affect on the data interpretation or conclusion of this
study, as the remaining groups of animals in this large
animal study generated sufficient data to draw a conclusion.
Clinical observation and mean daily weight gain
Signs of illness were not recognized in the pigs in the
21 day duration of the study except for the last day where
visible icterus and loss of body condition were observed in
three of eight mPCV2 pigs. The mean daily weight gain was
not different between groups (data not shown).
Anti-PCV2 antibody levels
All pigs were negative for anti-PCV2 IgG antibodies at
inoculation and the majority of the pigs remained negative
throughout the study due to the short 21 day duration of
the study. One of eight mPCV2 pigs did seroconvert to
PCV2 by 21 days p.i. and three of seven PCV2a pigs in
addition to one of seven PCV2b pigs had sample-to-
positive ratios within 0.1–0.2 and were considered suspect
positive (data not shown).
Prevalence and amount of PCV2 DNA in serum,
nasal swabs and faecal swabs
PCV2 DNA was not detected in any serum sample, nasal
swab or faecal swab collected from the negative control
pigs. The group means for PCV2a-, PCV2b- and mPCV2-
infected pigs are summarized in Fig. 1, and prevalence rates
and group means for all PCV2-infected groups are
summarized in Table 1. In serum samples at 7 days p.i.,
mPCV2-infected pigs had significantly higher amounts of
PCV2 DNA compared with PCV2b-infected pigs (Fig. 1a,
Table 1). Moreover, the prevalence of PCV2 DNA-positive
pigs was six of seven for PCV2a, four of seven for PCV2b
and eight of eight for mPCV2 at 7 days p.i. Thereafter, all
pigs in all infected groups were viraemic, and there was no
difference amongst PCV2a, PCV2b and mPCV2 groups;
however, the reciprocal chimeric PCV2 group had
significantly lower levels of PCV2 DNA compared with
mPCV2b by 21 days p.i. (Table 1).
In nasal swabs, PCV2 DNA was first detected in three of
eight mPCV2 pigs, one of six PCV2b-234-K pigs and three
of six reciprocal chimeric PCV2 pigs at 7 days p.i., and in
the other groups by 14 days p.i. (Fig. 1b, Table 1). In
general, the reciprocal chimeric PCV2 group shed the
lowest amounts of PCV2 DNA by the nasal route with
significant differences from PCV2a and PCV2b-234-K at
14 days p.i., and PCV2b at 21 days p.i. (Table 1).
In faecal swabs, PCV2 DNA was detected by 7 days p.i. in
two of seven PCV2a pigs, three of seven PCV2b pigs, four
of eight mPCV2 pigs, six of six PCV2b-234-K pigs and six
of six reciprocal chimeric PCV2 pigs (Table 1). When
comparing PCV2a, PCV2b and mPCV2 groups, signific-
antly higher amounts of PCV2 DNA were excreted by
mPCV2-infected pigs compared with PCV2b-infected pigs
at 14 days p.i. (Fig. 1c). When considering all groups, the
reciprocal chimeric PCV2b group had significantly lower
levels compared with all groups except PCV2b at 7 days p.i.
(Table 1).
Gross lesions
Macroscopic lesions were characterized by mild-to-severe
enlargement of lymph nodes in the majority of the pigs
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regardless of infection status. Several pigs (two of seven
negative controls, three of seven PCV2a pigs, five of seven
PCV2b pigs, two of six PCV2b-234-K pigs and one of six
reciprocal chimeric PCV2 pigs) had lesions consistent with
mild-to-severe chronic bacterial septicaemia (fibrinous
peritonitis, pleuritis, and pericarditis, fibrin tags on the
lung surface, and enlarged livers), and these pigs frequently
also had craniovental consolidation and tan or purple
discoloration of lung lobes resulting in lung scores of up to
43% of the lung surface affected (data not shown). Mild-
to-severe icterus, severe thymic atrophy, fatty liver and
serous atrophy of fat were present in three of eight mPCV2
pigs, and severe, diffuse interlobular oedema was present in
one of six reciprocal chimeric PCV2 pigs.
Microscopic lesions, PCV2 antigen in tissues and
PCVAD prevalence
Microscopic lesions were not present in lymphoid
tissues of the negative controls and PCV2 antigen was
also not detected in these pigs. The majority of the
PCV2-infected pigs, regardless of PCV2 subtype, had severe
lymphoid depletion of follicles and mild-to-moderate
histiocytic replacement of follicles in multiple lymphoid
tissues often associated with high amounts of PCV2
antigen (Table 2). An overall lymphoid lesions score of 7,
8 or 9, which is consistent with PCVAD (Opriessnig et al.,
2004), was evident in three of seven PCV2a pigs, four
of seven PCV2b pigs, four of eight mPCV2 pigs, five of
six PCV2b-234-K pigs and in one of six reciprocal
chimeric PCV2 pigs. Moderate multifocal lymphohistio-
tyic hepatitis (score 2) was present in three of seven
PCV2b pigs, one of eight mPCV2 pigs, one of six PCV2-
234-K pigs and one of six reciprocal chimeric PCV2 pigs.
Hepatic lesions were severe and diffuse (score 3) with
moderate hepatocyte degeneration in three of eight
mPCV2 pigs. Group mean hepatitis scores are summar-
ized in Table 2.
Prevalence and amount of PCV2 in lung and
lymphoid tissues
PCV2 DNA was detectable in lymphoid tissues and the
majority of the lung tissues in all infected pigs in all groups
(Table 2). Similarly, PCV2 antigen was detected in
lymphoid tissues in all but one infected pig (Table 2).
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Fig. 1. Mean group log10 amounts of PCV2 DNA detected in pigs at 7, 14 and 21 days p.i. with PCV2a, PCV2b or mPCV2: (a)
serum samples, (b) nasal swabs and (c) faecal swabs. Different superscripts at a certain day (A, B) indicate significant
differences between groups.
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Importance of the 234-K addition in ORF2
The log10 group mean PCV2 DNA genomic copies in
serum samples at 21 days p.i. (8.4±0.3 versus 7.3±0.3),
nasal swabs at 14 days p.i. (6.4±0.2 versus 5.7±0.2), and
faecal swabs at 14 days p.i. (8.1±0.3 versus 6.3±0.5) and
21 days p.i. (6.3±0.4 versus 4.5±0.4) were significantly
higher in ‘234-K’ virus-infected pigs compared with the
‘233’ virus-infected pigs. Moreover, PCVAD was diagnosed
in 40% (eight of 20) of the pigs infected with PCV2 strains
that did not possess the 234-K addition in ORF2 and in
64.3% (nine of 14) of the pigs that were infected with
PCV2s containing a lysine at position 234 (P50.29).
DISCUSSION
Although the increasing use of molecular techniques and
mathematical modelling has considerably advanced our
knowledge on infection dynamics, the determination of
differences in virus virulence still relies on utilization of in
vivo models. In the present study, infectious DNA clones
were constructed and used to produce biologically pure
homogeneous infectious stocks of various PCV2 viruses in
order to address and remove miscellaneous virus contam-
inations that may be present when utilizing virus stocks
obtained from naturally infected pigs. In this study, we also
used the CDCD pig model, which is known for its high
sensitivity to virus pathogenicity. The main finding in the
present study was the lack of marked differences in
virulence between PCV2a, PCV2b and mPCV2 strains.
All three viruses were capable of producing PCVAD in
young CDCD pigs. Whilst this is in line with previous
observations indicating that differences in virulence between
PCV2a and PCV2b genotypes are lacking (Opriessnig et al.,
2008), it is in contrast to a Chinese study that suggested that
mPCV2 is more virulent (Guo et al., 2012). In that study,
conventional pigs were utilized and infected with cell-
culture-propagated PCV2 isolates recovered from field cases.
It is well recognized that highly virulent viruses are
sometimes more difficult to propagate in vitro. In this
regard for PCV2, PCV2b is often more difficult to grow in
PK-15 cells compared with PCV2a (Guo et al., 2011). Based
on observations in our laboratory, the growth of mPCV2 in
PK-15 cells is even further reduced. However, pigs infected
experimentally with mPCV2 had earlier onset of viraemia
and higher viral shedding compared with pigs infected with
PCV2b. Similar to our study, the Chinese mPCV2-infected
pigs also had an earlier onset of viraemia compared with
PCV2a- and PCV2b-infected pigs; however, the majority of
the pigs in the Chinese study developed detectable viraemia
at ~14 days p.i., which is later than expected and later than
we observed in the present study in pigs infected with
infectious DNA clone-derived virus stocks. Differences in
sensitivity of PCR assays, the source of the infectious virus
stocks or infectious doses of the virus stocks utilized for
inoculation between studies may be responsible for the
discrepancies between studies. In the present study, aT
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quantitative real-time (qRT)-PCR assay targeting a con-
served region within ORF1 (Opriessnig et al., 2003) was
utilized for detection and quantification of the different
PCV2s. The reverse primer and the probe matched 100% at
the nucleic acid level with the corresponding ORF1 region of
the viruses in this study, whilst there was a nucleotide
mismatch at location 15 of the forward primer (‘T’ in the
primer versus ‘C’ in the PCV2 strains). This single mismatch
affected all three strains utilized (PCV2a, PCV2b and
mPCV2) and therefore the same efficiencies in amplification
can be assumed (Su¨ss et al., 2009). Nevertheless, the increased
ability of mPCV2 to replicate and shed early after infection
was evident in both studies, and this may explain whymPCV2
appears to be on its way to becoming the predominant PCV2
genotype. In addition, by 21 days p.i. only the mPCV2-
infected pigs had developed recognizable icterus, which was
associated with severe microscopic hepatitis.
In this study, a young CDCD pig model was utilized and pigs
were infected with infectious DNA clone-derived PCV2
isolates. Under field conditions, singular PCV2 infection is an
exception rather than the rule (Opriessnig & Halbur, 2012)
and the effect of co-infections of other swine pathogens on
mPCV2 virulence needs to be further determined. Recently,
no difference was found in viral growth and cytokine
production when macrophages were infected with PCV2a
and porcine reproductive and respiratory syndrome virus
(PRRSV) or PCV2b and PRRSV using several type 1 and 2
PRRSV isolates (Sinha et al., 2012). Similarly, no differences
were detected when PCV2a- or PCV2b-infected pigs were
concurrently infected with a type 2 PRRSV isolate (Sinha
et al., 2011). Emerging parvoviruses have been indicated as
possible contributing factors to mPCV2-associated clinical
manifestation of disease in vaccinated pigs (Opriessnig et al.,
2013), but this awaits further confirmation.
In this study, there were no significant differences in
virulence among distinct classical and emerging PCV2
isolates using a CDCD pig model. All isolates utilized were
capable of inducing severe disease in young pigs. Limita-
tions of the study include the naive immune system of
CDCD pigs and the young age at infection, which may have
contributed to artificial acceleration of clinical disease in this
model, and the short duration of the study, which may
have prevented a more pronounced antibody response.
Nevertheless, a higher frequency of PCVAD was observed in
pigs infected with mPCV2 strains containing 234 aa in the
capsid compared with those infected with PCV2 strains with
233 aa in this region, perhaps indicating some degree of
difference, which was supported by significantly higher
levels of PCV2 DNA in serum at 21 days p.i., nasal swabs at
14 days p.i., and faecal samples at 14 and 21 days p.i. in pigs
that were infected with mPCV2 containing the 234-K
addition in ORF2. Further investigations are warranted.
METHODS
Generation of infectious virus DNA clones. The construction of
the infectious DNA clones for PCV2a (isolate 40895) and PCV2bT
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(isolate NC16845) has been described previously (Beach et al., 2010;
Fenaux et al., 2002). The full-length infectious DNA clone of the
mPCV2 isolate JX535296 (Opriessnig et al., 2013) was amplified by
PCR using primers 1 and 3 (Table 3) from DNA extracted from a lung
homogenate of a 2012 Iowa pig with severe PCVAD (Xiao et al.,
2012). The PCR product was blunt ligated to the pCR Blunt II TOPO
vector using the Zero Blunt TOPO PCR Cloning kit (Life
Technologies) as per the manufacturer’s instructions.
In addition to PCV2a, PCV2b and mPCV2 infectious DNA clones, we
also constructed several chimeric, reciprocal chimeric and mutant
viruses between PCV2b and mPCV2 (Table 4, Fig. 2). To produce a
classical PCV2b infectious DNA clone with a 234 aa ORF2 similar to
that of mPCV2, the classical PCV2b strain NC16845 was modified
by site-directed mutagenesis. In brief, the site-directed mutagenesis
primers 11 and 12 were designed following the QuikChange muta-
genesis kit guidelines (Agilent Technologies) and mutagenesis was
performed per the QuikChange II Site-Directed Mutagenesis kit
protocol (Agilent Technologies) on the NC16845-based PCV2b
infectious DNA clone.
To produce chimeric virus strains between PCV2b and mPCV2, the
ORF1 and ORF2 of PCV2b strain NC16845 and mPCV2 strain
JX535296 were utilized. In brief, overlapping extension PCRs were
performed for NC16845 ORF1 and JX535296 ORF2 as well as
JX535296 ORF1 and NC16845 ORF1 as described previously (Beach
et al., 2010). Full-length chimeric clones were produced by assembling
three overlapping PCR fragments. For construction of chimeric
PCV2b, the NC16845 template and primers 1 and 2 as well as primers
3 and 4 were utilized, and the JX535296 template and primers 5 and 6
were also used. For the construction of the reciprocal chimeric PCV2,
the JX535296 template was used with primers 1 and 7 and primers 3
and 8, and the NC16845 template was used with primers 9 and 10.
Each amplicon was produced using Accuzyme Mix (Bioline) (95 uC
10 min; 35 cycles of 95 uC 30 s, 54 uC 30 s, 68 uC 30 s, followed by
68 uC for 1.5 min). The fusion PCR was performed to assemble the
full-length chimeric genomes (95 uC 10 min; 35 cycles of 95 uC 30 s,
60 uC 30 s, 68 uC 30 s, followed by 68 uC for 4 min). The full-length
fusion products were blunt ligated to the pCR Blunt II TOPO vector
using the Zero Blunt TOPO PCR Cloning kit (Life Technologies) per
the manufacturer’s instructions. Each DNA clone was fully sequenced
to confirm the authenticity of each construct.
Production of the infectious virus stocks. A subclone of the PK-
15 cell line free of PCV1 contamination as described previously
(Fenaux et al., 2002) was used to produce and titrate infectious virus
stocks for this study. PCV2a, PCV2b, mPCV2, PCV2b-234-K,
chimeric and reciprocal chimeric PCV2 virus stocks were obtained
by isolation of each of the full-length virus genomes and con-
catemerization, followed by transfection of the concatemerized DNA
clones into PK-15 cells as described previously (Opriessnig et al.,
2006b). Briefly, the full-length viral genomes were excised from the
respective plasmid using the SacII restriction enzyme. The digested
genomes were self-ligated using the CloneDirect Rapid Ligation kit
(Lucigen). The concatemerized viral genomes were then transfected
into PK-15 cells and an immunofluorescence assay (IFA) with a
PCV2-specific antibody was used to determine infectious virus titres
as described previously (Fenaux et al., 2002). Virus production was
analysed by IFA using a mouse anti-PCV2 capsid primary mAb (Rural
Technologies) and a goat anti-mouse FITC-labelled mAb (KPL).
Animals, housing and experimental design. The experimental
protocol was approved by the Iowa State University Institutional
Animal Care and Use Committee. Forty-seven CDCD pigs were
purchased at 2 weeks of age and arbitrarily assigned to one of seven
groups and rooms with six to eight pigs in each group (Table 4). The
pigs were housed in raised plastic decks equipped with one nipple
drinker and one self-feeder. All groups were fed ad libitum with a
balanced, pelleted feed ration (Nature’s Made). Virus challenge was
done at 3 weeks of age. Each group was challenged with a different
PCV2 strain as outlined in Table 4 by a combination of intramuscular
and intranasal routes. At 6 weeks of age, corresponding to 21 days p.i.,
all pigs were humanely euthanized and a necropsy was conducted.
Clinical observation and mean daily weight gain. All pigs were
weighed at arrival at 2 weeks of age and at the time of necropsy at 6
weeks of age. The mean daily weight gain was calculated and compared
among groups. All pigs were examined daily for signs of illness,
including lethargy, respiratory signs, inappetence, icterus and lameness.
Virus challenge. Following the determination of TCID50 titres for
each virus using the Reed–Muench method, all virus stocks were
adjusted to 103.66 TCID50 ml
21 for the pig inoculations. The
inoculum stock was each sequenced around the ORF2 region to
verify the authenticity of respective virus stock. The inoculum stocks
were stored at 280 uC until usage. Each pig received 5 ml of the
respective inoculum (56103.66 TCID50 titre per pig) (Table 4) by a
combination of the intranasal route (slowly dripping 1.5 ml into each
of the two nostrils) and the intramuscular route (intramuscular
injection of 2 ml into the right neck area).
Sample collection. Blood was collected from all pigs prior to
challenge, and again at 7, 14 and 21 days p.i. in 8.5 ml serum
Table 3. Primers utilized for generation of the infectious virus clones
Primer ID Primer sequence
1 59-TTTCCGCGGGCTGGCTGAACTTTTGAAAG-39
2 59-ACCCCCCACTTAACCCTAAGTGAATAATAAAAACCATTAC-39
3 59-AGCCCGCGGAAATTTCTGACAAACGTTAC-39
4 59-CCTCCTTGGATACGTCATATCTGAAAACGAAAGAA-39
5 59-GTTTTTATTATTCACTTAGGGTTAAGTGGGGGG-39
6 59-CTTTCGTTTTCAGATATGACGTATCCAAGGAGGCG-39
7 59-CCACTTAACCCTTAATGAATAATAAAAACCATTAC-39
8 59-CCTCCTTGGATACGTCATCGCTGAAAACGAAAGAA-39
9 59-CTTTCGTTTTCAGCGATGACGTATCCAAGGAGGCG-39
10 59-GTTTTTATTATTCATTAAGGGTTAAGTGGGGGGT-39
11 59-TTTTTATCACTTCGTAATGGTTTTTATTATTCACTTAGGGTTAAGTGGGGGGT-39
12 59-ACCCCCCACTTAACCCTAAGTGAATAATAAAAACCATTACGAAGTGATAAAAA-39
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separator tubes (Fisher Scientific). The blood was centrifuged at
2000 g for 10 min at 4 uC and serum was stored at 280 uC until
testing. In addition, nasal and faecal samples were collected weekly
from each pig using polyester swabs (Fisher Scientific). Swabs were
stored in 5 ml plastic tubes (Fisher Scientific) containing 1 ml sterile
saline solution (Fisher Scientific). Lung tissues and inguinal lymph
node samples were collected during necropsy at 21 days p.i., and
stored in separate bags at 280 uC until testing.
Necropsy. All pigs were humanely euthanized by intravenous
pentobarbital sodium overdose (Fatal Plus; Vortech Pharmaceuticals)
and necropsied at 21 days p.i. The extent of macroscopic lung lesions
ranging from 0 to 100% was scored as described previously (Halbur
et al., 1995). The sizes of superficial inguinal lymph nodes were
compared among groups as described (Opriessnig et al., 2006a).
Sections of lymph nodes (superficial inguinal, external iliac, medi-
astinal, tracheobronchial and mesenteric), tonsil, heart, thymus,
kidney, colon, spleen, liver, and small (ileum) and large (spiral colon)
intestines were fixed in 10% neutral-buffered formalin, and routinely
processed for histological examination. In addition, lung and
superficial inguinal lymph nodes were collected in separate bags, and
stored at 280 uC for further PCR testing.
Serology. Serum samples were tested by an ORF2-based PCV2 IgG
ELISA as described previously (Nawagitgul et al., 2002) and were
considered positive if the sample-to-positive ratio was¢0.2. Samples
with sample-to-positive ratios between 0.1 and 0.2 were considered
suspect.
DNA extraction. Lung and superficial inguinal lymph node samples
of ~1 g were minced and diluted 1 : 10 in Hank’s balanced salt
solution, homogenized by using a Stomacher 80 (Seward Laboratory
Systems) and centrifuged at 1500 g for 10 min to obtain supernatant.
Total nucleic acids were extracted from serum samples, nasal swabs,
faecal swabs, lung homogenates or superficial inguinal lymph node
homogenates using the MagMax Pathogen RNA/DNA kit (Applied
Biosystems) and an automated DNA/RNA extraction system
(Kingfisher Flex; Thermo Fisher Scientific) according to the
instructions of the manufacturer.
Detection and quantification of viral nucleic acids. All serum
samples, lung homogenates and superficial inguinal lymph node
homogenates were tested for the presence of PCV2 DNA by qRT-PCR
assays using primer/probe combinations as described (Opriessnig
et al., 2003; Shen et al., 2010b) with the following modifications: a
commercially available master mix (TaqMan Universal PCR Master
Mix; Applied Biosystems) was used, the reaction volume was 25 ml,
only one replica was tested for each sample, and the thermal cycler
conditions were 50 uC for 2 min, 95 uC for 10 min, followed by 40
cycles of 95 uC for 10 s and 60 uC for 1 min. Samples were considered
negative when no signal was observed within the 40 amplification
cycles. Five serial dilutions of a PCV2 genomic DNA clone (105–109
copies ml21) were used to generate a standard curve with a
correlation coefficient of .0.99 (Opriessnig et al., 2003).
Sequence confirmation of authentic inoculum. All PCV2 DNA-
positive serum samples were further tested with PCV2a/PCV2b/
mPCV2 differential PCR assays (Opriessnig et al., 2010, 2013) to
determine the PCV2 genotype. The original inoculum stock and a
PCV2 DNA-positive serum sample collected at 21 days p.i. in each
group and room were sequenced. In brief, a conventional PCR
covering the entire ORF2 was utilized as described previously (Gerber
et al., 2013). The obtained 768 bp products were sequenced at the
Iowa State University DNA Facility. Sequences were aligned with
Table 4. Group designations, original viruses utilized and ORF origin of each virus construct
Group designation No. of CDCD pigs PCV2 strain ORF1 ORF2
Negative controls 7 Saline NA NA
PCV2a 7 40895 PCV2a PCV2a
PCV2b 7 NC16845 PCV2b PCV2b
mPCV2 8 JX535296 mPCV2 mPCV2
PCV2b-234-K 6 NC16845 with lysine ORF2 position 234 PCV2b PCV2b+K
Chimeric PCV2 6 NC16845 and JX535296 PCV2b mPCV2
Reciprocal chimeric PCV2 6 JX535296 and NC16845 mPCV2 PCV2b
NA, Not applicable.
PCV2a
40895 NC16845ORF2ORF1 ORF2ORF1 ORF2ORF1 JX535296
NC16845
NC16845
NC16845
ORF2ORF1 ORF2ORF1 ORF2ORF1
JX535296
JX535296
PCV2b mPCV2
PCV2b-234-K Reciprocal chimeric PCV2 Chimeric PCV2
Fig. 2. Schematic representation of the virus
origins of the infectious clones constructed in
this study. K indicates that there is an
additional lysine in ORF2, which has a length
of 234 aa residues instead of 233 aa.
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published data using BLAST (http://www.ncbi.nlm.nih.gov/), and
compiled using Lasergene 11 software and the CLUSTAL V alignment
algorithm (DNASTAR).
Histopathology and immunohistochemistry (IHC). Microscopic
lesions were evaluated by two veterinary pathologists (T.O. and
P. G.H.) blinded to the treatment group status. Lung sections were
scored for the presence and severity of interstitial pneumonia, ranging
from 0 (normal) to 6 (severe diffuse) (Halbur et al., 1995). Sections of
heart, liver, kidney, ileum, colon, brain and thymus were evaluated for
the presence of inflammation, and scored from 0 (none) to 3 (severe).
Lymph nodes, spleen and tonsil were evaluated for presence of
lymphoid depletion and granulomatous replacement of follicles
ranging from 0 (normal) to 3 (severe) (Opriessnig et al., 2004).
Detection of PCV2-specific antigen using IHC was performed on
sections of lymph nodes, tonsil and spleen using a rabbit PCV2
polyclonal antiserum (Sorden et al., 1999). PCV2 antigen scoring was
done by a veterinary pathologist (T. O.) blinded to animal group
designation. Scores ranged from 0 (no signal) to 3 (.50% of
lymphoid follicles contained cells with PCV2 antigen staining)
(Opriessnig et al., 2004).
Overall lymphoid lesion score. The overall lymphoid lesion score
was calculated as described previously (Opriessnig et al., 2004). In
brief, a combined scoring system for each lymphoid tissue that ranged
from 0 to 9 (lymphoid depletion score 0–3; inflammation score 0–3;
PCV2 IHC score 0–3) was used. The combined scores of the
lymphoid tissues were divided by the number of tissues (Opriessnig
et al., 2004).
Statistical analysis. For data analysis, JMP Pro software version
10.0.2 (SAS Institute) was used. Summary statistics were calculated
for all the groups to assess the overall quality of the dataset, including
normality. Statistical analysis of the data was performed by one-way
ANOVA for continuous data (log10-transformed PCR data, ELISA
data and mean daily weight gain). A P value ,0.05 was set as the
statistically significant level. A pairwise test using Tukey’s adjustment
was subsequently performed to determine which differences among
groups were statistically different. Serum qRT-PCR results (copies
ml21) were log10 transformed prior to statistical analysis. Non-
repeated nominal data (histopathology scores) were assessed using a
non-parametric Kruskal–Wallis one-way ANOVA; if there was a
significant difference, pairwise Wilcoxon tests were used to evaluate
differences among groups. Differences in prevalence were determined
by using x2 tests. In line with the objectives, PCV2a (n57), PCV2b
(n58) and mPCV2 (n58) groups were compared initially. In a
subsequent step, all groups were compared. For completeness, the
importance of the 234 mutation in ORF2 was also evaluated by using
the following groups: ORF2 233 (PCV2a, PCV2b and reciprocal
chimeric PCV2 groups, n520) versus ORF2 234 (mPCV2 and
PCV2b-234-K groups, n514).
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